XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock and additional paid-in capital
Treasury Stock
Accumulated other comprehensive income (loss)
Retained Earnings
Beginning Balance (in shares) at Dec. 31, 2020 2,685 3,672      
Beginning Balance (in shares) at Dec. 31, 2020     (987)    
Beginning Balance at Dec. 31, 2020 $ 34,280 $ 486,829 $ (15,325) $ 526 $ (437,750)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation (in shares)   3      
Stock-based compensation   $ 302      
Purchase of treasury stock (in shares)     0    
Purchase of treasury stock     $ (2)    
Purchase of restricted stock from employees (in shares)     0    
Purchase of restricted stock from employees     $ 0    
Other comprehensive income (loss)       (226)  
Net income (loss) $ (203)       (203)
Ending Balance (in shares) at Mar. 31, 2021 2,688 3,675      
Ending Balance (in shares) at Mar. 31, 2021     (987)    
Ending Balance at Mar. 31, 2021 $ 34,151 $ 487,131 $ (15,327) 300 (437,953)
Beginning Balance (in shares) at Dec. 31, 2021 2,707 3,694      
Beginning Balance (in shares) at Dec. 31, 2021 987   (987)    
Beginning Balance at Dec. 31, 2021 $ 39,316 $ 489,253 $ (15,329) (85) (434,523)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation (in shares)   105      
Stock-based compensation   $ 546      
Purchase of treasury stock (in shares)     0    
Purchase of treasury stock     $ 0    
Purchase of restricted stock from employees (in shares)     (7)    
Purchase of restricted stock from employees     $ (226)    
Other comprehensive income (loss)       137  
Net income (loss) $ 3,019       3,019
Ending Balance (in shares) at Mar. 31, 2022 2,805 3,799      
Ending Balance (in shares) at Mar. 31, 2022 994   (994)    
Ending Balance at Mar. 31, 2022 $ 42,792 $ 489,799 $ (15,555) $ 52 $ (431,504)